Evidence map›Paper›PMID 32734505›Full record

Observational studyInternational urology and nephrology2020

Reduced serum CTRP12 levels in type 2 diabetes are associated with renal dysfunction.

Jinqiu Du, Jiajia Xu, Xiaoguang Wang, Yanyan Liu, Xue Zhao, Huijuan Zhang

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in International urology and nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jinqiu DuDepartment of Endocrinology and Metabolic Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Jiajia XuDepartment of Endocrinology and Metabolic Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Xiaoguang WangDepartment of Endocrinology and Metabolic Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Yanyan LiuDepartment of Endocrinology and Metabolic Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Xue ZhaoDepartment of Endocrinology and Metabolic Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Huijuan ZhangDepartment of Endocrinology and Metabolic Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China. hydzhj@126.com.ORCID http://orcid.org/0000-0003-3703-5242
Harbin Medical University · CN

Funding

the National Natural Science Foundation of China 81202189the Natural Science Foundation of Heilongjiang Province H2016040
6 · The paper itself

Abstract

purposeSerum C1q/TNF-related protein-12 (CTRP12) is one of the newly studied families of adipokines, which is believed to be associated with type 2 diabetes. However, the relationship between serum CTRP12 levels and diabetic nephropathy remains unclear. This study aimed to investigate the relationship between serum CTRP12 levels and renal function in patients with type 2 diabetes.

methodsA total of 115 type 2 diabetic patients and 54 healthy subjects were enrolled in this study. 52 patients with type 2 diabetes were in the diabetes group (T2DM). The 63 patients with renal dysfunction were diabetic nephropathy group (T2DM-DN) and were divided into microalbuminuria subgroup (31 cases) and macroalbuminuria subgroup (32 cases) according to the 24-h urine protein excretion rate. The concentrations of serum CTRP12 were determined by enzyme-linked immunosorbent assay.

resultsSerum CTRP12 level in T2DM and T2DM-DN groups was significantly lower compared with the control group, while CTRP12 level in T2DM-DN group was significantly lower than that in T2DM group, and was associated with the severity of renal insufficiency. After adjusting for gender and age, serum CTRP12 level was negatively correlated with the duration of diabetes, blood urea nitrogen (BUN), uric acid (UA) and 24-h urinary albumin excretion rate (UAE) in T2DM patients. Logistic regression analysis showed that serum CTRP12 level was significantly associated with renal dysfunction in type 2 diabetes mellitus. And the duration of diabetes, total cholesterol (CHOL) and neutrophils/lymphocytes (NLR) are independent risk factors for renal dysfunction in type 2 diabetes mellitus.

conclusionSerum CTRP12 may be involved in the occurrence and development of diabetic nephropathy. Trial registration number and date of registration ChiCTR2000030794, March 14, 2020.

Indexed as

AdipokinesAdultAgedCross-Sectional StudiesDiabetes Mellitus, Type 2Diabetic NephropathiesFemaleHumansKidneyMaleMiddle AgedAdipokinesC1QTNF12 protein, humanAdipocytokinesC1q/TNF-related protein-12 (CTRP12)Diabetic renal dysfunctionType 2 diabetes

Identifiers

PMID32734505
OpenAlexW3046806753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.